Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease

BACKGROUND: In Huntington’s disease (HD), the ratio between normal and mutant Huntingtin (polyQ-hHtt) is crucial in the onset and progression of the disease. As a result, addition of normal Htt was shown to improve polyQ-hHtt-induced defects. Therefore, we recently identified, within human Htt, a 23...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Arribat, Yoan, Talmat-Amar, Yasmina, Paucard, Alexia, Lesport, Pierre, Bonneaud, Nathalie, Bauer, Caroline, Bec, Nicole, Parmentier, Marie-Laure, Benigno, Lorraine, Larroque, Christian, Maurel, Patrick, Maschat, Florence
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149238/
https://ncbi.nlm.nih.gov/pubmed/25091984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-014-0086-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires